# GLP-1 Users Face Higher Heat-Related Health Risks During Summer
People taking GLP-1 medications like Ozempic, Wegovy, and Mounjaro need to take extra precautions during hot weather. These drugs increase vulnerability to dehydration and heat-related illness, experts warn.
GLP-1 receptor agonists work by slowing gastric emptying and increasing feelings of fullness. This mechanism reduces appetite but also decreases thirst signals. Users often eat and drink less overall, leaving them at risk during temperature spikes.
Heat compounds the problem. Higher temperatures increase fluid loss through perspiration. Combined with reduced water intake from the medication's effects, dehydration develops quickly. Dehydration then triggers cascading problems: dizziness, fatigue, confusion, and in severe cases, heat exhaustion or heat stroke.
Dr. Rekha Kumar, an endocrinologist at New York-Presbyterian, notes that GLP-1 users should prioritize hydration even when they don't feel thirsty. "The medication suppresses your thirst mechanism," Kumar explains. "You need to drink proactively, not reactively."
Additionally, these medications can affect kidney function and electrolyte balance. Heat stress amplifies these effects. Users who experience nausea from their GLP-1 dose face even greater dehydration risk since vomiting depletes fluids and electrolytes rapidly.
Practical steps help reduce danger. GLP-1 users should drink water consistently throughout the day, regardless of thirst. They should limit outdoor activities during peak heat hours (10am to 4pm), wear light clothing, and monitor urine color as a hydration indicator. Dark urine suggests inadequate fluid intake.
Users should also alert their healthcare provider about summer plans, especially if traveling to hot climates.